Effect of Baseline Thrombocytopenia on Long-Term Outcomes in Patients With Acute ST-Segment Elevated Myocardial Infarction ― A Large Propensity Score-Matching Analysis From the China Acute Myocardial Infarction (CAMI) Registry ―
Authors:
Open Access
- 25 January 2021
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 85 (2) , 150-158
Abstract
Background:Data on the association of baseline thrombocytopenia (TP) with long-term outcomes of patients with acute ST-segment elevated myocardial infarction (STEMI) are still limited.Methods and Results:A total of 16,957 consecutive cases of patients with STEMI from multiple centers that participated in the China Acute Myocardial Infarction (CAMI) registry were included in this study. Two-year clinical outcomes were evaluated between patients with TP and those with a normal platelet count (PLT). Cases coexisting with baseline TP accounted for 2.1%. The rates of 2-year all-cause death (21.4% and 11.4%, P<0.001) and major adverse cardiovascular and cerebrovascular events (MACCE) (23.6% and 13.9%, P<0.001) were significantly higher in cases with TP, compared with the normal PLT group. After multivariate adjustment, compared with the control, cases with TP were not independently associated with 2-year all-cause death (HR: 1.21; 95% CI: 0.96–1.52; P=0.110) and MACCE (HR: 1.18; 95% CI: 0.95–1.47; P=0.132). After propensity score matching (PSM), the rates of 2-year all-cause death and MACCE were similar between the 2 groups (20.7% and 17.9%, P=0.317; 23.0% and 19.9%, P=0.288). Multivariable adjustment after PSM showed baseline TP was not independently associated with all-cause death (HR: 1.21; 95% CI: 0.88–1.67; P=0.240) and MACCE (HR: 1.21; 95% CI: 0.89–1.63; P=0.226).Conclusions:Patients with STEMI and baseline TP had higher rates of all-cause death and MACCE; however, baseline TP was not independently associated with 2-year adverse outcomes in patients with STEMI after multivariate adjustment and controlling for baseline differences.Keywords
This publication has 22 references indexed in Scilit:
- Incidence, predictors and outcome of upper gastrointestinal bleeding in patients with acute coronary syndromesInternational Journal of Cardiology, 2012
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)European Heart Journal, 2011
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: Analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trialAmerican Heart Journal, 2011
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2009
- Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial InfarctionCirculation, 2009
- Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary interventionAmerican Heart Journal, 2008
- Acute coronary disease in essential thrombocythemia and polycythemia veraJournal of Internal Medicine, 1998
- ThrombocytopeniaAACN Advanced Critical Care, 1997
- Platelet Size in Stroke PatientsStroke, 1995